Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed) | RFA DK 26 002

Opportunity Information: Apply for RFA DK 26 002

The Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed) is an NIH funding opportunity from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) designed to strengthen coordination, collaboration, and information-sharing across NIDDK-supported benign urology research programs. It is built around the idea that the impact of the George M. O'Brien Urology Research Centers (U54) and the Exploratory Centers for Interdisciplinary Research in Benign Urology (P20), along with related institutional career development programs (K12), increases when the different centers and communities are intentionally connected rather than operating in isolation. The U24 "Interactions Core" is meant to function as the organizing hub that makes those connections routine, productive, and visible to the broader scientific and clinical urology communities.

At its core, this award supports a centralized effort that helps the U54 and P20 Centers work together more effectively, while also creating structured pathways for engagement with other NIDDK training and scientific efforts. In practical terms, the Interactions Core is expected to serve as a focal point for establishing collaborations, fostering interdisciplinary exchanges, and promoting ongoing communication among investigators, trainees, clinicians, and other stakeholders. The emphasis is on benign urologic diseases and disorders and on activities that amplify the mission of the larger Centers Programs, including strengthening the pipeline and development of the next generation of urology researchers. Because the opportunity is labeled "Clinical Trial Not Allowed," applicants should plan a scope of work that does not include conducting clinical trials, and instead focuses on coordination, convening, network-building, programmatic support, and other non-trial activities that enable and accelerate research across the participating programs.

Mechanistically, this is a cooperative agreement (U24), which typically means NIH expects substantial involvement in the direction or stewardship of the award compared with a standard research project grant. The funding opportunity number is RFA-DK-26-002, the agency is NIH, and it falls under the broader activity category of health (CFDA 93.847). The posted award ceiling is $500,000, indicating the expected maximum level of support per award (as stated in the source information). The original application due date listed is 2024-11-21, and the opportunity was created on 2024-09-11.

Eligibility is broad across U.S.-based organizations and includes many government entities (state, county, city/township, special districts), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), and small businesses, along with Native American tribal governments (federally recognized) and other Native American tribal organizations. The NOFO also explicitly highlights additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. However, non-domestic (non-U.S.) entities are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed, reinforcing that the work and participating organizational structure must be fully domestic.

Overall, the opportunity is best understood as support for the connective tissue of the NIDDK benign urology research ecosystem: a dedicated Interactions Core that improves collaboration among the U54 and P20 Centers, links those centers with NIDDK-related training and scientific initiatives like K12 programs, and extends engagement outward to the broader urology research and clinical communities, all without proposing clinical trial activities.

• The National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
• This funding opportunity was created on 2024-09-11.
• Applicants must submit their applications by 2024-11-21. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $500,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA DK 26 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: